Furthermore, it was shown that metabolic dysfunctions, including obesity, insulin resistance, adipose tissue inflammation, lipid accumulation, and dysregulated glucose metabolism, can trigger NLRP3 inflammasome activation in various tissues, including the liver and the brain. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.